Using integrated modeling to support the global eradication of vaccine-preventable diseases
- PMID: 34552305
- PMCID: PMC8455164
- DOI: 10.1002/sdr.1589
Using integrated modeling to support the global eradication of vaccine-preventable diseases
Abstract
The long-term management of global disease eradication initiatives involves numerous inherently dynamic processes, health and economic trade-offs, significant uncertainty and variability, rare events with big consequences, complex and inter-related decisions, and a requirement for cooperation among a large number of stakeholders. Over the course of more than 16 years of collaborative modeling efforts to support the Global Polio Eradication Initiative, we developed increasingly complex integrated system dynamics models that combined numerous analytical approaches, including differential equation-based modeling, risk and decision analysis, discrete-event and individual-based simulation, probabilistic uncertainty and sensitivity analysis, health economics, and optimization. We discuss the central role of systems thinking and system dynamics in the overall effort and the value of integrating different modeling approaches to appropriately address the trade-offs involved in some of the policy questions. We discuss practical challenges of integrating different analytical tools and we provide our perspective on the future of integrated modeling.
Keywords: decision analysis; health economics; integrated modeling; polio eradication; systems thinking.
Figures
Similar articles
-
A Collaborative Initiative to Strengthen Sustainable Public Health Capacity for Polio Eradication and Routine Immunization Activities in the Eastern Mediterranean Region.JMIR Public Health Surveill. 2019 Oct 29;5(4):e14664. doi: 10.2196/14664. JMIR Public Health Surveill. 2019. PMID: 31663863 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
An Updated Economic Analysis of the Global Polio Eradication Initiative.Risk Anal. 2021 Feb;41(2):393-406. doi: 10.1111/risa.13665. Risk Anal. 2021. PMID: 33590521 Free PMC article.
-
Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention.Vaccine. 2013 Apr 18;31 Suppl 2:B149-56. doi: 10.1016/j.vaccine.2012.11.091. Vaccine. 2013. PMID: 23598476 Review.
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
Cited by
-
Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV).Pathogens. 2024 Sep 17;13(9):804. doi: 10.3390/pathogens13090804. Pathogens. 2024. PMID: 39338995 Free PMC article.
-
Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame.Med Decis Making. 2023 Oct-Nov;43(7-8):850-862. doi: 10.1177/0272989X231191127. Epub 2023 Aug 14. Med Decis Making. 2023. PMID: 37577803 Free PMC article.
-
Local distribution infrastructure and robust vaccine manufacturing facilities in LMICs should be prioritised to tackle ongoing and future pandemic risk.Lancet Reg Health Southeast Asia. 2023 Feb 21;11:100158. doi: 10.1016/j.lansea.2023.100158. eCollection 2023 Apr. Lancet Reg Health Southeast Asia. 2023. PMID: 37384365 Free PMC article. No abstract available.
-
Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation.Front Public Health. 2023 Mar 24;11:1098419. doi: 10.3389/fpubh.2023.1098419. eCollection 2023. Front Public Health. 2023. PMID: 37033033 Free PMC article. Review.
-
Collaboration-competition dilemma in flattening the COVID-19 curve.Prod Oper Manag. 2022 Apr 14:10.1111/poms.13709. doi: 10.1111/poms.13709. Online ahead of print. Prod Oper Manag. 2022. PMID: 35601840 Free PMC article.
References
-
- Alexander JP Jr., Ehresmann K, Seward J, Wax G, Harriman K, Fuller S, Cebelinkski EA, Chen Q, Jorba J, Kew OM, Pallansch MA, Oberste MS, Schleiss M, Davis JP, Warshawsky B, Squires S and Hull HF (2009). “Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota.” Journal of Infectious Diseases 199(3): 391–397. - PubMed
-
- Anderson RM and May RM (1991). Infectious diseases of humans: dynamics and control. New York, Oxford University Press.
-
- Anis E, Kopel E, Singer S, Kaliner E, Moerman L, Moran-Gilad J, Sofer D, Manor Y, Shulman L, Mendelson E, Gdalevich M, Lev B, Gamzu R and Grotto I (2013). “Insidious reintroduction of wild poliovirus into Israel, 2013.” Euro Surveillance 18(38): pii=20586. - PubMed
-
- Arita I, Nakane M and Fenner F (2006). “Public health. Is polio eradication realistic?” Science 312(5775): 852–854. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources